Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

15
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
15
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

14
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
14

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hook effect for ferritin immunoassays: implications for clinical practice.

Clinical chemistry and laboratory medicine·2025
Same author

Validation of Dried Blood Spot Immunoreactive Trypsinogen as a Biomarker of Exocrine Pancreas Function in Children With Pancreas Disease.

The American journal of gastroenterology·2025
Same author

New Psychoactive Substances: A Canadian perspective on emerging trends and challenges for the clinical laboratory.

Clinical biochemistry·2024
Same author

Self-management intervention for patients following hospitalization for acute exacerbation of chronic obstructive pulmonary disease (AECOPD): A pilot randomized controlled trial.

Nursing & health sciences·2024
Same author

Behavioral Weight Loss Interventions for Overweight and Obese Cardiac Rehabilitation Patients: A Systematic Review.

Western journal of nursing research·2023
Same author

Analytical Unreliability of 25 Hydroxy Vitamin D Measurements in Pre-Term Neonates.

The journal of applied laboratory medicine·2023
Same journal

Cardiovascular disease and miRNA.

Advances in clinical chemistry·2026
Same journal

RNA biomarkers in antidoping.

Advances in clinical chemistry·2026
Same journal

Biomarkers for assessing magnesium status.

Advances in clinical chemistry·2026
Same journal

Advances in microfluidic extracellular vesicle technology.

Advances in clinical chemistry·2026
Same journal

Chronic low-grade inflammation in vegetarians and vegans: Biomarker evidence and methodological considerations.

Advances in clinical chemistry·2026
Same journal

Biomarkers in heart failure.

Advances in clinical chemistry·2026
查看所有相关文章

相关实验视频

Updated: Jul 11, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

849

在产前的测试方面取得的进展.

Jessica J Miller1, Victoria Higgins2, Annie Ren3

  • 1Dynacare, Brampton, ON, Canada.

Advances in clinical chemistry
|November 16, 2023
PubMed
概括
此摘要是机器生成的。

像胎盘生长因子 (PlGF) 和可溶性FMS,如氨酸激酶1 (sFlt-1) 这样的孕前的生物标志物提供了更好的诊断准确性. 这些标志物对于及时识别和管理子宫前至关重要,提高母亲和胎儿的安全.

关键词:
临床实践指南 临床实践指南诊断性表现 诊断性表现实验室测试 实验室测试 实验室测试胎盘生长因子 (PlGF)孕前症 孕前症可溶性FMS类似于氨酸激酶 (sFlt-1) 的

更多相关视频

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

10.7K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

15.9K

相关实验视频

Last Updated: Jul 11, 2025

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles
05:31

Author Spotlight: Modeling an Aspect of Preeclampsia in Female Mice Using Hypoxic Human Placenta-Derived Small Extracellular Vesicles

Published on: January 26, 2024

849
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
12:17

The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo

Published on: August 2, 2017

10.7K
Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption
12:02

Human Primary Trophoblast Cell Culture Model to Study the Protective Effects of Melatonin Against Hypoxia/reoxygenation-induced Disruption

Published on: July 30, 2016

15.9K

科学领域:

  • 产科和妇科 产科和妇科
  • 孕产妇和胎儿医学 孕产妇和胎儿医学
  • 临床化学 临床化学

背景情况:

  • 孕前是一种严重的高血压疾病,导致严重的孕产妇和胎儿并发症.
  • 目前的诊断方法,包括高血压,蛋白尿和肝酶测试,缺乏特异性和敏感性.
  • 对于可靠的生物标志物来早期和准确地检测子宫前有着至关重要的需求.

研究的目的:

  • 审查产前的临床特征和发病因子,重点关注血管性因素.
  • 检查目前临床实践指南和实验室测试建议,以诊断子宫前.
  • 为了评估可用的胎盘生长因子 (PlGF) 和可溶性FMS,如氨酸激酶1 (sFlt-1) 试验,用于临床实用.

主要方法:

  • 对孕前的临床特征的审查.
  • 分析血管生成因子 (PlGF,sFlt-1) 在孕前病原发生中的作用.
  • 对诊断标准的临床实践指南的评估.
  • 评估PlGF和sFlt-1试验的方法,分析性能和临床价值.

主要成果:

  • 孕前的诊断依赖于非特异性临床症状和实验室测试.
  • 像PlGF和sFlt-1这样的血管性因素与孕前的发病因子有关.
  • 现有的plgf和sflt-1测定显示了不同程度的分析性能和临床实用性.

结论:

  • 像plgf和sflt-1这样的生物标志物有望改善孕前的诊断和管理.
  • 需要进一步的研究来优化这些生物标志物的分析和临床方面.
  • 改进的诊断工具对于减少与孕前相关的孕产妇和胎儿发病率和死亡率至关重要.